Associated Papers
JAK/STAT in human diseases: a common axis in immunodeficiencies and hematological disorders.
Djidjik R et al.
Frontiers in Immunology, 2025
41438753 (PubMed )
Supplement: Table1.pdf
Malignancy in STAT3 Deficient Hyper IgE Syndrome.
Urban A et al.
Journal of Clinical Immunology, 2022
Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance.
Asano T et al.
The Journal of Experimental Medicine, 2021
34137790 (PubMed )
Supplement: JEM_20202592_TableS3.xlsx › Table_S2
Staphylococcus aureus and Hyper-IgE Syndrome.
Park B et al.
International Journal of Molecular Sciences, 2020
Structural Implications of STAT3 and STAT5 SH2 Domain Mutations.
de Araujo ED et al.
Cancers, 2019
Visualization and quantification of dynamic STAT3 homodimerization in living cells using homoFluoppi.
Okada Y et al.
Scientific Reports, 2018
Protein stabilization improves STAT3 function in autosomal dominant hyper-IgE syndrome.
Bocchini CE et al.
Blood, 2016
Consequences of the disease-related L78R mutation for dimerization and activity of STAT3.
Domoszlai T et al.
Journal of Cell Science, 2014
A STAT3 mutation in hyper-immunoglobulin E syndrome: A case report.
Haenen F et al.
Journal of Pediatric Genetics, 2013
STAT3 mutations correlated with hyper-IgE syndrome lead to blockage of IL-6/STAT3 signalling pathway.
He J et al.
Journal of Biosciences, 2012
Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3.
Paulson ML et al.
Current Opinion in Allergy and Clinical Immunology, 2008
STAT3 mutations in the hyper-IgE syndrome.
Holland SM et al.
The New England Journal of Medicine, 2007
Select a paper to view details